SNTI — Senti Biosciences Holdings, Inc.

—
Nasdaq · Health Care · Biotechnology · CIK 1854270 ·
Last close
$0.10
Market Cap
$3.02M
52W High
$2.88
52W Low
$0.09
ADV30
6,707,358
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 19,000 — -12,322,000 -11,586,000 28,359,000 5,553,000 37,963,000
Jun 2026 17,000 — -14,489,000 -12,750,000 33,105,000 6,463,000 36,506,000
Mar 2026 16,000 — -11,498,000 -4,221,000 38,241,000 8,935,000 35,676,000
Dec 2025 22,000 — -13,584,000 -14,467,000 51,223,000 16,420,000 45,634,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-38,051,000
Investing CF
$114,000
Financing CF
$20,721,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.77
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-375,543,000
Inventory
—
Receivables
$557,000
ST Investments
—
EBIT TTM
$-56,519,000
Pretax Income TTM
$-49,564,000
Interest Exp TTM
—
Analysts
2

Yahoo Snapshot (yfinance, live)

Total Revenue
$55,000
EBITDA
$-50,167,000
Free Cash Flow
$-17,112,376
Enterprise Value
$23,149,294
Total Cash
$6,607,000
Total Debt
$20,226,000
Shares Out
31,144,754
Trailing EPS
$-1.69
Book Value
$-0.11
ROE
-466.5%
ROA
-65.6%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 22,000 -63,727,000 -61,438,000 51,223,000 45,634,000 5,589,000 -43,444,000
Dec 2024 0 -60,726,000 -52,790,000 97,841,000 72,192,000 25,649,000 -41,397,000
Dec 2023 1,978,000 -66,765,000 -71,058,000 119,484,000 52,571,000 66,913,000 -52,395,000
Dec 2022 3,286,000 -62,084,000 -58,210,000 180,792,000 53,529,000 127,263,000 -34,896,000

TTM Snapshot

Revenues TTM
$55,000
NetIncome TTM
$-49,564,000
OpCashFlow TTM
—
Assets (Latest)
$33,105,000
Forward EPS
$-0.95

Peers — same industry

TickerNameMarket CapLastDaily %
BCAB BioAtla, Inc. $3.00M $1.80 —
ABPO Abpro Holdings, Inc. $2.65M $0.45 —
CELZ CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. $3.62M $0.48 —
CRIS CURIS INC $3.62M $0.54 —
VIVS VivoSim Labs, INC. $2.44M $0.12 —

News headlines (Yahoo Finance, 1h cache)

Senti Biosciences Holdings, Inc. Announces a Strategic Transaction to Unlock Value for its Gene-Circuit-Enabled Pipeline, Including SENTI-202, and to Sharpen its Focus on Next-Generation Controllable
2026-07-15 11:30 · Yahoo
Senti Biosciences Announces Publication in Cell Systems Demonstrating Advanced Logic-Gated CAR Design for Cell Therapies
2026-04-01 12:45 · Yahoo
Senti Biosciences to Present on Logic-Gated Cell Therapies in Educational Session at AACR Annual Meeting 2026
2026-04-13 13:00 · Yahoo
Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Update
2026-05-14 12:40 · Yahoo
Senti Bio Announces Reverse Stock Split
2026-11-17 13:00 · Yahoo
BC-Most Active Stocks
2026-10-27 14:30 · Yahoo
Senti Biosciences Holdings Reports First Quarter 2026 Financial Results and Highlights Advancement of SENTI-202 Program into Pivotal Phase
2026-05-14 12:45 · Yahoo
Senti Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
2026-03-27 12:00 · Yahoo
Senti Biosciences to Present Clinical and Translational Data on SENTI-202 at the 11th Annual Innate Killer Conference
2026-03-23 13:00 · Yahoo
Senti Biosciences to Present at Leerink Partners 2026 Global Healthcare Conference
2026-03-03 14:05 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.